Skip to main content
. 2022 Apr 29;7(3):384–394. doi: 10.1182/bloodadvances.2021006440

Figure 4.

Figure 4.

Effects of IL-15 injections on additional IL-15–responsive lymphocyte subpopulation in participants with ATL and PTCL. (A-C) Average fold increases + standard deviation of CD4+ T, CD8+ T, and γδ+ T cells among PBMCs after IL-15 treatment are shown for each treatment group. (D-F) Total numbers of respective proliferating Ki67+ cells for each patient before and after treatment. ∗P < .01; ∗∗P < .001; NS, not significant.